Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.937 EUR | -0.11% | +3.77% | +3.59% |
Apr. 17 | Sonae Unit Closes Purchase of Majority Stake in BCF Life Sciences-owner Diorren | MT |
Mar. 19 | Sonae Issues EUR150 Million Bonds | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Its low valuation, with P/E ratio at 6.96 and 8.78 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The stock, which is currently worth 2024 to 0.4 times its sales, is clearly overvalued in comparison with peers.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Retail & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.59% | 1.93B | B+ | ||
-7.21% | 38.45B | A- | ||
+11.52% | 35.53B | C | ||
+9.36% | 33.86B | A | ||
+9.52% | 20.2B | B | ||
+1.92% | 14.29B | B | ||
-17.40% | 12.77B | B- | ||
-.--% | 11.82B | - | - | |
+16.48% | 11.85B | B- | ||
-3.89% | 11.75B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SON Stock
- Ratings Sonae - SGPS, SA